Vibrations: Vibration Building Design for Cancer Center Part 1

Critical industries need building infrastructure that eliminates even the slightest whisper of the wind or rumblings of public transit miles away. Sensitive instruments used in mission-critical research, testing, and product equipment must exist in a vibration-free environment. Industry-leading TCM understands these needs, and their products have become an essential tool for vibration control to solve building vibration challenges. Ahmad Bayat, P.E., President at Vibro-Acoustic Consultants, and Mike Georgalis, North American Sales Manager at the Technical Manufacturing Corporation (TMC), joined Vibrations’ host, Daniel J. Litwin, for an in-depth 3-part discussion on vibration control strategies and technologies, including insight on a recent Cancer research lab project with a challenging micro-vibration design. In this first episode, Bayat and Georgalis laid the foundation for understanding mission-critical environments’ challenges with building vibrations.

“The world of micro and nano-scale that involves not only life sciences but in many of the industries where R&D is needed, besides the manufacturing and production, it’s migrated to nano-scale these days,” Bayat said. “Not only scientists are looking at the subatomic structure of a cancer cell, or it could be a semiconductor component, but on top of that, they are looking at and manipulating the atomic and subatomic structure. So, the challenge for all of us is to make precision tools operate successfully to allow the scientists to perform what they need to do in terms of manipulating and analyzing different species.” And in this case study, the precision needed involves cancer cells.

To conquer this world of vibrations at a nano-scale level may pose challenges. Still, they’re ones Bayat and Georgalis enjoy taking on no matter the industry requiring such cutting-edge technology.

“These types of problems are common problems, and they need to be solved in different places around the world and in a lot of different industries,” Georgalis said. “A good example is in the semiconductor industry where the big microchip manufacturers are pushing the limits to how small a microchip they can make.” These chips require manufacturing conditions without vibrations, and thus these companies rely on partners like TCM to create vibrationless solutions.

Follow us on social media for the latest updates in B2B!

Image

Latest

Doable
Rethinking Leadership: Why “Doable” Might Be the Most Powerful Strategy in Education Today
April 3, 2026

At a time when educator burnout is rising and schools across the U.S. are facing ongoing teacher shortages, leaders are being forced to rethink what sustainable success actually looks like. Research shows that teacher attrition is closely tied to working conditions, job-related stress, and workload demands. As districts push for innovation, data-driven instruction, and…

Read More
Casey Brown
From Poverty to Pricing Power | Why Great Companies Undercharge
April 2, 2026

Casey Brown didn’t grow up thinking she would become an entrepreneur. She grew up in a blue-collar family where money was always tight — close enough to the edge that the fear of poverty shaped many of her early decisions. That fear led her into engineering, into corporate America, and eventually into a moment…

Read More
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
April 2, 2026

In this episode of Care Anywhere, host Lea Sims sits down with Nigerian nurse entrepreneur and advocate Obafemi Arowosegbe to discuss leadership, mentorship, and the future of nursing in Africa. While still a nursing student, Obafemi founded the Nightingale Summit, a growing conference designed to empower nursing students and early-career nurses with leadership skills,…

Read More
Oncology
From Denial to Access: Rethinking Oncology Care Through AI, Clinical Trials, and Patient-Centered Innovation
April 1, 2026

The rapid expansion of precision medicine, biologics, and targeted cancer therapies is transforming oncology—but it’s also overwhelming a system not built to keep pace. In the U.S., cancer drugs now account for some of the highest-cost treatments in healthcare, and with that has come a surge in prior authorization requirements and denials. Studies suggest physicians…

Read More